Almoosa Health Company Stocks

SAR 138.8Last Updated 27.04.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

SAR 1.64B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SAR 138.8
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Almoosa Health Company operates as a private healthcare provider in Saudi Arabia. The company stores medical items; and sells medicines, cosmetics, and disposable medical items. It also operates hospitals and pharmacies; and provides acute care, active rehabilitation, long-term care, and home healthcare services, as well as healthcare education services. The company was founded in 1996 and is based in Al Mubarraz, Saudi Arabia. Almoosa Health Company operates as a subsidiary of Abdulaziz bin Abdullah Almoosa Investment Company.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 4018.SR is 175 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks